Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.
about
Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDSEffects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamicsTransgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practicesA randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Unmet need for family planning, contraceptive failure, and unintended pregnancy among HIV-infected and HIV-uninfected women in Zimbabwe.Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, MalawiGonadal function and reproductive health in women with human immunodeficiency virus infection.Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women.Dual Protection and Dual Methods in Women Living with HIV: The Brazilian Context.Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional surveyThe effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception.Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011.Integrating family planning and prevention of mother to child HIV transmission in Zimbabwe.Fertility-related research needs among women at the margins.Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.From Pill to Condom, or Nothing at all: HIV Diagnosis and Discontinuation of Highly Effective Contraceptives Among Women in Northeast Brazil.Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: A Systematic review.The 'post-condom era' or the urgent need to provide effective contraception for women living with HIV.Contraceptive Choice and Use of Dual Protection Among Women Living with HIV in Canada: Priorities for Integrated Care.Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study.The 16th Bangkok International Symposium on HIV Medicine
P2860
Q26851185-FA25892E-B076-40F6-9C1E-1E9EC4DFF24AQ26998835-156D3A3C-7414-45EC-9FC2-536570359DE9Q28067469-9F736F34-45AA-43C5-A754-748760675417Q33763511-7ABFDF70-D4A4-424D-A437-F25738EE9C93Q34075440-830EBF28-91B1-4858-8335-3E3E10312CD8Q34111289-9283142F-F76A-4D84-9FF0-CA5A10DE6BD2Q34117651-20D2840D-3867-4495-A899-0743BA6E0E7FQ35033605-21185A2B-24DE-4297-B2D3-445DB0A8D96BQ35623705-0123D6C1-BD6F-486C-B50A-F6A8A3CB4B71Q36016655-A6B4AF59-8D9F-4783-8D59-C951C3CD41FCQ36306216-61C0613E-1037-416B-8D08-C28E11E51147Q36343568-51270A90-5FEE-43E9-83B5-BB0A7C4E1DF7Q36446880-076CA417-5D87-4C3F-B3AC-767B30392AE9Q37662721-9ED817DB-3C06-4010-98E7-AD48097EDECFQ38567814-BAF4D49E-8BF7-4A0C-9D53-9EF781AA3814Q38686382-2C898ED6-C71E-4B1F-9852-CB841B061EC2Q38855739-822013A4-6609-4D51-BB95-56C889AE216EQ40106510-CA21B190-F396-4750-9422-1C0C7C5A7E0FQ40143664-3B8CB126-6EE1-4BE1-B01D-C1F50D6A8137Q41694386-61411987-E25F-401A-B68D-FB0EB3828460Q42365533-53C044A5-93DB-4A60-8931-D0AF7CCCFB95Q47570774-043D7CB5-FB2E-45EF-A6B5-98AE3C72FBD0Q48524975-280EDCC1-5591-4535-A5B0-41A695F255DEQ50036499-A4C64778-82D3-4E7B-B04B-DE7B0EA34575Q58815106-240AD566-2C9E-4306-8EDD-2CFE24944222
P2860
Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@ast
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@en
type
label
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@ast
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@en
prefLabel
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@ast
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@en
P2093
P2860
P921
P356
P1476
Contraception for the HIV-posi ...... on and antiretroviral therapy.
@en
P2093
Anne E Burke
Jennifer A Robinson
Roxanne Jamshidi
P2860
P304
P356
10.1155/2012/890160
P577
2012-08-14T00:00:00Z